Cyabra, Inc. has announced a significant private placement agreement aimed at raising $15.6 million through the issuance of Series D Preferred Stock. This strategic move is designed to enhance the company's financial stability and support general corporate purposes. The agreement also includes provisions for potential management changes, indicating a shift in the company's leadership structure.
On November 15, 2026, Cyabra entered into a Securities Purchase Agreement with certain institutional investors. The initial closing of this agreement is contingent upon the satisfaction of specific conditions, including stockholder approvals and compliance with Nasdaq listing requirements. As of now, the initial closing has not yet occurred, and the company has not received the anticipated proceeds.
Background
Cyabra, Inc. operates in the prepackaged software sector, classified under the SIC code 7372. The company is listed on the Nasdaq under the ticker symbol CYAB. Cyabra has been actively engaging in various financial maneuvers, including recent filings that indicate its ongoing efforts to strengthen its capital structure and operational capabilities.
What the Filing Says
The SEC filing details that the Securities Purchase Agreement includes an initial closing amount of $15,610,120, which comprises $10 million in new investment and $5,610,120 from the cancellation of existing debt. The Series D Preferred Stock will have a stated value of $1,000 per share, with an initial conversion price of $0.15 per share. The agreement also allows for additional investments of up to $30 million over a three-year period, subject to specific conditions.
Impact
This funding initiative may significantly affect Cyabra's operational capabilities, allowing for enhanced working capital and potential growth opportunities. The move may also influence the broader prepackaged software industry as companies explore similar funding strategies to navigate current market conditions.
What's Next
Following the initial closing, Cyabra has agreed to consider management changes, which may include the appointment of Joe Hayon as President, Nir Brenmiller as a director, and Roy Hass as Chairman of the Board. The company is expected to file a registration statement for the resale of shares within two days following the initial closing of the offering.
Read Next
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
MiniMed Group receives FDA clearance for new insulin pump
TC Energy unveils expansion plans for NGTL System
Onto Innovation announces $400 million share buyback program
iPower Inc. secures $2 million through convertible note deal








